The AMPK activator Metformin also displays anti-cancer activity, particularly in cases of melanoma in which cancer cell growth is inhibited through direct effects on miR-192-5p-EFEMP1 and miR-584-3p-SCAMP3 pathways [13]. This evidence concerns the gene EFEMP1 and melanoma.